Chapter 27. Bioisosterism in Drug Design
- 1 January 1986
- book chapter
- Published by Elsevier
- Vol. 21, 283-291
- https://doi.org/10.1016/s0065-7743(08)61137-9
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analog inhibitorJournal of Medicinal Chemistry, 1985
- A general distance-geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitorsJournal of Medicinal Chemistry, 1984
- Chapter 30. Recent Progress in the Rational Design of Peptide Hormones and NeurotransmittersPublished by Elsevier ,1984
- Bioisosteric design of conformationally restricted pyridyltriazole histamine H2-receptor antagonistsJournal of Medicinal Chemistry, 1983
- Conformational restrictions of biologically active peptides via amino acid side chain groupsLife Sciences, 1982
- A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistryJournal of Medicinal Chemistry, 1981
- Chapter 19. Peptides of the HypothalamusPublished by Elsevier ,1981
- The physicochemical approach to drug design and discovery (QSAR)Drug Development Research, 1981
- Isosterism and molecular modification in drug designChemical Society Reviews, 1979
- On the concept of linear modified retro-peptide structuresAccounts of Chemical Research, 1979